- Home
- CHR vs CLRB Comparison
CHR vs CLRB Comparison
Compare CHR & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- CLRB
- Stock Information
- Founded
- CHR 2016
- CLRB 2002
- Country
- CHR China
- CLRB United States
- Employees
- CHR N/A
- CLRB N/A
- Industry
- CHR EDP Services
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- CHR Technology
- CLRB Health Care
- Exchange
- CHR Nasdaq
- CLRB Nasdaq
- Market Cap
- CHR 13.3M
- CLRB 14.2M
- IPO Year
- CHR N/A
- CLRB N/A
- Fundamental
- Price
- CHR $0.71
- CLRB $5.48
- Analyst Decision
- CHR
- CLRB Hold
- Analyst Count
- CHR 0
- CLRB 2
- Target Price
- CHR N/A
- CLRB N/A
- AVG Volume (30 Days)
- CHR 772.0K
- CLRB 97.0K
- Earning Date
- CHR 07-30-2025
- CLRB 11-17-2025
- Dividend Yield
- CHR N/A
- CLRB N/A
- EPS Growth
- CHR N/A
- CLRB N/A
- EPS
- CHR 1.76
- CLRB N/A
- Revenue
- CHR $147,134,000.00
- CLRB N/A
- Revenue This Year
- CHR N/A
- CLRB N/A
- Revenue Next Year
- CHR N/A
- CLRB N/A
- P/E Ratio
- CHR $0.39
- CLRB N/A
- Revenue Growth
- CHR N/A
- CLRB N/A
- 52 Week Low
- CHR $0.65
- CLRB $4.11
- 52 Week High
- CHR $3.45
- CLRB $67.50
- Technical
- Relative Strength Index (RSI)
- CHR 29.55
- CLRB 59.90
- Support Level
- CHR $0.65
- CLRB $5.05
- Resistance Level
- CHR $0.73
- CLRB $5.34
- Average True Range (ATR)
- CHR 0.10
- CLRB 0.34
- MACD
- CHR 0.00
- CLRB 0.07
- Stochastic Oscillator
- CHR 10.18
- CLRB 97.64
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.